Table 5.
KEGG associations for the mammary development, prolactin signalling and involution pathways
|
Mammary development | ||
|---|---|---|
| ID | Pathway | Nb Genes |
| bta05200 |
Pathways in cancer |
25 |
| bta05166 |
HTLV-I infection |
14 |
| bta04151 |
PI3K-Akt signalling pathway |
14 |
| bta04060 |
Cytokine-cytokine receptor interaction |
12 |
| bta04630 |
Jak-STAT signalling pathway |
10 |
| bta05217 |
Basal cell carcinoma |
9 |
| bta04380 |
Osteoclast differentiation |
8 |
| bta05218 |
Melanoma |
8 |
| bta04310 |
Wnt signalling pathway |
8 |
| bta04010 |
MAPK signalling pathway |
8 |
|
Prolactin signalling | ||
|
ID |
Pathway |
Nb Genes |
| bta04630 |
Jak-STAT signalling pathway |
12 |
| bta04151 |
PI3K-Akt signalling pathway |
8 |
| bta04910 |
Insulin signalling pathway |
6 |
| bta04380 |
Osteoclast differentiation |
5 |
| bta05200 |
Pathways in cancer |
5 |
| bta05161 |
Hepatitis B |
5 |
| bta05164 |
Influenza A |
5 |
| bta04920 |
Adipocytokine signalling pathway |
5 |
| bta05162 |
Measles |
5 |
| bta04060 |
Cytokine-cytokine receptor interaction |
5 |
|
Involution | ||
|
ID |
Pathway |
Nb Genes |
| bta05200 |
Pathways in cancer |
18 |
| bta04630 |
Jak-STAT signalling pathway |
15 |
| bta05161 |
Hepatitis B |
14 |
| bta04151 |
PI3K-Akt signalling pathway |
13 |
| bta05166 |
HTLV-I infection |
9 |
| bta05203 |
Viral carcinogenesis |
9 |
| bta05152 |
Tuberculosis |
8 |
| bta05213 |
Endometrial cancer |
8 |
| bta05210 |
Colorectal cancer |
7 |
| bta05202 | Transcriptional misregulation in cancer | 7 |